Daniel S. Kapp

13.4k total citations · 3 hit papers
328 papers, 9.3k citations indexed

About

Daniel S. Kapp is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology. According to data from OpenAlex, Daniel S. Kapp has authored 328 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Obstetrics and Gynecology, 90 papers in Reproductive Medicine and 71 papers in Oncology. Recurrent topics in Daniel S. Kapp's work include Endometrial and Cervical Cancer Treatments (95 papers), Ovarian cancer diagnosis and treatment (85 papers) and Ultrasound and Hyperthermia Applications (48 papers). Daniel S. Kapp is often cited by papers focused on Endometrial and Cervical Cancer Treatments (95 papers), Ovarian cancer diagnosis and treatment (85 papers) and Ultrasound and Hyperthermia Applications (48 papers). Daniel S. Kapp collaborates with scholars based in United States, Taiwan and Germany. Daniel S. Kapp's co-authors include John K. Chan, Kathryn Osann, Jacob Y. Shin, Nelson N.H. Teng, Amreen Husain, Michael K. Cheung, Jonathan S. Berek, Kendric C. Smith, Hwa–Young Son and N. N. Teng and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Daniel S. Kapp

311 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

2006 482 citations Chad A. Hamilton, Kathryn Osann et al. profile →
Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017

2022 94 citations Cheng-I Liao, Daniel S. Kapp et al. profile →
Transition versus physical climate risk pricing in European financial markets: a text-based approach

2024 84 citations Giovanna Bua, Daniel S. Kapp et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel S. Kapp United States	53	3.5k	3.3k	1.9k	1.9k	1.6k	328	9.3k
Anaís Malpica United States	64	3.7k 1.1×	5.4k 1.6×	2.3k 1.2×	2.3k 1.3×	2.5k 1.6×	281	13.0k
Anthony Fyles Canada	56	3.8k 1.1×	2.1k 0.6×	2.6k 1.4×	2.8k 1.5×	1.7k 1.1×	270	12.1k
Perry W. Grigsby United States	61	5.5k 1.6×	2.3k 0.7×	3.2k 1.7×	1.4k 0.8×	2.0k 1.3×	250	11.1k
Sushil Beriwal United States	40	3.5k 1.0×	1.4k 0.4×	2.7k 1.4×	2.0k 1.1×	1.7k 1.1×	405	8.2k
Anuja Jhingran United States	44	4.0k 1.2×	1.8k 0.5×	2.3k 1.2×	2.0k 1.1×	937 0.6×	261	7.7k
Arno J. Mundt United States	51	3.6k 1.0×	1.3k 0.4×	3.0k 1.6×	1.7k 0.9×	2.9k 1.8×	259	9.1k
Patricia J. Eifel United States	59	8.3k 2.4×	3.7k 1.1×	4.7k 2.5×	2.7k 1.5×	1.9k 1.2×	263	13.3k
Wim L.J. van Putten Netherlands	56	1.6k 0.5×	1.5k 0.4×	1.5k 0.8×	2.6k 1.4×	2.8k 1.8×	155	10.5k
Domenica Lorusso Italy	46	3.3k 1.0×	4.9k 1.5×	2.6k 1.4×	3.6k 2.0×	1.2k 0.7×	521	9.7k
Peter G. Rose United States	54	6.5k 1.9×	5.8k 1.8×	4.1k 2.2×	3.2k 1.7×	1.9k 1.2×	274	12.2k

Countries citing papers authored by Daniel S. Kapp

Since Specialization

Citations

This map shows the geographic impact of Daniel S. Kapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Kapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Kapp more than expected).

Fields of papers citing papers by Daniel S. Kapp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Kapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Kapp. The network helps show where Daniel S. Kapp may publish in the future.

Co-authorship network of co-authors of Daniel S. Kapp

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel S. Kapp. A scholar is included among the top collaborators of Daniel S. Kapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel S. Kapp. Daniel S. Kapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kapp, Daniel S., et al.. (2025). Suicide rates of cervical cancer patients in the United States – Who is most at risk? A retrospective study of 69,493 patients. Journal of Cancer Policy. 44. 100586–100586. 1 indexed citations

Hoffmann, Manuela A., Çiğdem Soydal, Irene Virgolini, et al.. (2025). Management Based on Pretreatment PSMA PET of Patients with Localized High-Risk Prostate Cancer Part 2: Prediction of Recurrence—A Systematic Review and Meta-Analysis. Cancers. 17(5). 841–841. 1 indexed citations

Tian, Chunqiao, Chad A. Hamilton, Michael Richardson, et al.. (2024). Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States. Cancers. 16(5). 1071–1071. 1 indexed citations

Eyben, Finn Edler von, Kalevi Kairemo, & Daniel S. Kapp. (2024). Prostate-Specific Antigen as an Ultrasensitive Biomarker for Patients with Early Recurrent Prostate Cancer: How Low Shall We Go? A Systematic Review. Biomedicines. 12(4). 822–822.

Liao, Cheng-I, Jenny Chang, Krishnansu S. Tewari, et al.. (2024). Endometrial cancer and obesity trends in the United States in the 21st century.. Journal of Clinical Oncology. 42(16_suppl). 5507–5507. 1 indexed citations

Liao, Cheng-I, et al.. (2024). Increase in uterine cancer incidence among Black patients in the United States: A United States Cancer Statistics Study of nearly 95,000 patients from 2001 to 2019. Gynecologic Oncology. 190. S73–S74. 1 indexed citations

Eyben, Finn Edler von, Karsten Kristiansen, Daniel S. Kapp, et al.. (2023). Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis. International Journal of Molecular Sciences. 24(4). 4148–4148. 6 indexed citations

Richardson, Michael, Kristopher Attwood, Gabriella Smith, et al.. (2023). Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey. Cancer Control. 30. 2915600843–2915600843. 6 indexed citations

Islam, Md Tauhidul, Daniel S. Kapp, James Zou, et al.. (2023). Revealing hidden patterns in deep neural network feature space continuum via manifold learning. Nature Communications. 14(1). 8506–8506. 37 indexed citations

10.

Bua, Giovanna, Daniel S. Kapp, Friderike Kuik, & Eliza Lis. (2021). EU emissions allowance prices in the context of the ECB’s climate change action plan. RePEc: Research Papers in Economics. 6. 6 indexed citations

11.

Bua, Giovanna, et al.. (2021). Transition Versus Physical Climate Risk Pricing in Euro Area Financial Markets: A Text-Based Approach. SSRN Electronic Journal. 6 indexed citations

12.

Chan, John K., Su‐Ying Liang, Daniel S. Kapp, et al.. (2020). Selecting new upfront regimens for advanced ovarian cancer with biomarker guidance. Gynecologic Oncology. 159(3). 604–606. 2 indexed citations

13.

Mann, Amandeep, et al.. (2019). Relative importance of diet and physical activity in cancer survival: An analysis of the US national health and nutrition examination survey. Gynecologic Oncology. 154. 220–220. 1 indexed citations

14.

Rao, Vamshi K., Daniel S. Kapp, & Mary Schroth. (2018). Gene Therapy for Spinal Muscular Atrophy: An Emerging Treatment Option for a Devastating Disease. Journal of Managed Care & Specialty Pharmacy. 24(12-a Suppl). S3–S16. 44 indexed citations

15.

Kapp, Daniel S., et al.. (2018). Euro area sovereign bond market liquidity since the start of the PSPP. RePEc: Research Papers in Economics. 2. 1 indexed citations

16.

Kapp, Daniel S., et al.. (2017). Factors associated with oophorectomy in children with benign ovarian masses. International Journal of Gynecology & Obstetrics. 138(3). 356–357. 1 indexed citations

17.

Chan, John K., et al.. (2016). The influence of age and other prognostic factors associated with survival of ovarian immature teratoma — A study of 1307 patients. Gynecologic Oncology. 142(3). 446–451. 12 indexed citations

18.

Yu, Xinhua, Deirdre Lum, T. Kiet, et al.. (2012). Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. Journal of Surgical Oncology. 107(6). 653–658. 28 indexed citations

19.

Chan, John K., Alexander E. Sherman, Daniel S. Kapp, et al.. (2011). Influence of Gynecologic Oncologists on the Survival of Patients With Endometrial Cancer. Journal of Clinical Oncology. 29(7). 832–838. 78 indexed citations

20.

Kapp, Daniel S., et al.. (2000). Malignant granular cell tumor of the vulva in a 17-year-old: Case report and literature review. International Journal of Gynecological Cancer. 10(5). 429–434. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact